Login / Signup

Dabrafenib and trametinib combination therapy safely performed in a patient with metastatic melanoma after severe liver toxicity due to vemurafenib.

Shuichi ShimadaSatoshi FukushimaDaisuke NiimoriAzusa MiyashitaHiroko SetoyamaYutaka SasakiHironobu Ihn
Published in: The Journal of dermatology (2018)
Keyphrases
  • combination therapy
  • case report
  • early onset
  • oxidative stress
  • drug induced